Valuing tonsillitis manifestations in schoolchildren in Rio de Janeiro

Abstract

Objective: To evaluate the importance attributed to tonsillitis by guardians and their level of knowledge about the disease, correlating their management with their schooling and socioeconomic profiles. Methods: A quantitative, descriptive and observational crosssectional study involving students aged 5 to 17 years from state-owned and private schools. A questionnaire was applied on management of tonsillitis and knowledge about rheumatic fever, addressing demographic and socioeconomic data. Results: A total of 323 students were included, predominantly females (61.3%), from state-owned schools (77.1%), with a mean age of 9.7±0.3 years. Among the guardians, 48.6% completed high school. Among the students 75.2% had at least one episode of odynophagia in the previous 12 months. Considering the previous 2 years, 89.8% reported this symptom. There was no collection of bacteriological specimens in 67.8%, and in 83% if taking into account only the last episode, despite the search for medical care in most cases (92.6%). The use of anti-inflammatory drugs was very frequent (43.0% "always" and 42.4% "sometimes"). Among the guardians, 81.7% denied being aware of the relation between rheumatic fever and inappropriate treatment of odynophagia; 85.8% said they wished they had received more information. Conclusion: Although it is quite common in schoolchildren, tonsillitis is neglected by many guardians and health professionals, and the ignorance of its relation with rheumatic fever is practically universal, which may contribute to its high prevalence.

Therapeutic and diagnostic approaches in the treatment of chronic tonsillitis

“…В современных российских клинических рекоменда циях выбор метода лечения зависит от формы ХТ, но при щадящем подходе к иммунокомпетентному органу врачи первичного звена начинают курсовое консервативное лечение с санации небных миндалин с учетом рекомен даций оториноларинголога [26]. Применение системной антибактериальной терапии рекомендовано только в двух случаях: при подтвержденной БГСА-инфекции или при устойчивом повышении АСЛО, остальным пациентам рекомендованы противовоспалительная фармакотера пия и последовательное назначение различных комбина ций препаратов природного происхождения, оказываю щих комплексное действие на ключевые звенья патоге неза ХТ [39][40][41][42][43][44][45][46]. Таким образом, актуально исследование влияния противомикробного фитопрепарата на основе экстракта корней пеларгонии сидовидной на симптомы ХТ и лабораторные критерии эффективности комплекс ного противовоспалительного лечения.…”